• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 Agency for Healthcare Research and Quality (AHRQ) Treatment for glaucoma: comparative effectiveness
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Alternative methods for the treatment of post-menopausal troubles]
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [CT coronary angiography versus conventional invasive coronary angiography in CHD]
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Clinical effectiveness and cost-effectiveness of central venous catheters treated with minocycline and rifampicin in preventing bloodstream infections in intensive care patients]
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Effectiveness of geriatric rehabilitation among patients with secondary diagnosis dementia]
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Therapy of the burnout syndrome]
2012 Agency for Healthcare Research and Quality (AHRQ) Systematic review of decision tools and their suitability for patient-centered decisionmaking regarding electronic cardiac devices
2012 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Development and validation of methods for quality assessment of health technologies assessment reports. Evaluation of the quality of qualitative studies]
2012 NIHR Health Technology Assessment programme Abiraterone acetate for the treatment of metastatic, castrate-resistant prostate cancer following previous cytotoxic chemotherapy
2012 NIHR Health Technology Assessment programme Botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine
2012 NIHR Health Technology Assessment programme Erlotinib for the first-line treatment of EGFR-TK mutation positive non-small-cell lung cancer
2012 NIHR Health Technology Assessment programme Rivaroxaban for the treatment of deep vein thrombosis and secondary prevention of venous thromboembolism
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bioprothesis Perceval S, sutureless aortic valve replacement]
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Treatment of aortic stenosis with the sutureless ATS 3f Enable bioprothesis]
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) The clinical effectiveness and cost of a pneumococcal urine antigen immunochromatographic test (BinaxNOW Streptococcus pneumoniae) in the diagnosis of community acquire Streptococcus pneumoniae pneumonia in patients admitted to hospital
2012 NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: OVA1™ test for the assessment of suspected ovarian cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Xpert MTB/RIF® test for tuberculosis
2012 NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: RealTime mS9 Colorectal Cancer (CRC) Assay for the early detection of colorectal cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) in combination with trastuzumab and chemotherapy for HER2-positive, node-positive or high risk node-negative breast cancer – adjuvant therapy
2012 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) with trastuzumab and paclitaxel for HER2 positive locally advanced or metastatic breast cancer – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Farletuzumab for ovarian cancer: relapsed, platinum-sensitive – in combination with carboplatin and a taxane
2012 NIHR Horizon Scanning Centre (NIHR HSC) NGR-TNF for malignant pleural mesothelioma – second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Nintedanib (Vargatef) for epithelial ovarian, fallopian tube or primary peritoneal carcinoma: advanced (stage IIB-IV) – first or second line; in combination with carboplatin and paclitaxel following initial surgery, where indicated
2012 NIHR Horizon Scanning Centre (NIHR HSC) Panobinostat (Faridak) for relapsed or refractory multiple myeloma
2012 NIHR Horizon Scanning Centre (NIHR HSC) SAR-302503 for myelofibrosis – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) HPV OncoTect® E6 E7 mRNA Assay to guide colposcopy referral in cervical cancer screening
2012 NIHR Horizon Scanning Centre (NIHR HSC) Empagliflozin for type 2 diabetes mellitus
2012 NIHR Horizon Scanning Centre (NIHR HSC) VBLOC® vagal blocking therapy for obesity
2012 NIHR Horizon Scanning Centre (NIHR HSC) Naloxegol (NKTR-118) for opioid-induced constipation
2012 NIHR Horizon Scanning Centre (NIHR HSC) ALFApump® System for ascites due to liver cirrhosis
2012 NIHR Horizon Scanning Centre (NIHR HSC) Collagenase clostridium histolyticum (Xiapex) for Dupuytren's contracture – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Tolvaptan for autosomal dominant polycystic kidney disease
2012 NIHR Horizon Scanning Centre (NIHR HSC) Transportable haemodialysis machines for established renal failure
2012 NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for plaque psoriasis
2012 NIHR Horizon Scanning Centre (NIHR HSC) Brivanib alaninate for hepatocellular cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) Cilengitide (Impetreve) for glioblastoma multiforme
2012 NIHR Horizon Scanning Centre (NIHR HSC) Clofarabine (Evoltra) for acute myeloid leukaemia in older adults unsuitable for anthracycline-based combination chemotherapy
2012 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) in combination with trastuzumab and vinorelbine for HER2/neu positive, locally advanced or metastatic breast cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) Iniparib (Tivolza) in combination with gemcitabine and carboplatin for stage IV squamous non-small cell lung cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib in combination with capecitabine and oxaliplatin for advanced gastric, oesophageal or gastro-oesophageal cancer – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) in combination with trastuzumab for HER2-positive metastatic breast cancer – second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) in combination with a taxane for HER2-positive metastatic breast cancer – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) MDV-3100 for castration-resistant prostate cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) in combination with chlorambucil for chronic lymphocytic leukaemia – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Cabozantinib for medullary thyroid cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) FENIX® Continence Restoration System for severe chronic faecal incontinence
2012 NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: SpringTMS™ Total Migraine System
2012 HAYES, Inc. Epidermal Growth Factor Receptor (EGFR) sequence variant analysis for predicting response to Non-Small Cell Lung Cancer (NSCLC) drug therapy
2012 NIHR Horizon Scanning Centre (NIHR HSC) Bioresorbable stents for occlusive coronary artery disease
2012 NIHR Horizon Scanning Centre (NIHR HSC) Darbepoetin alfa (Aranesp) for anaemia in symptomatic heart failure
2012 NIHR Horizon Scanning Centre (NIHR HSC) Edoxaban tosylate for the treatment and secondary prevention of venous thromboembolic events
2012 NIHR Horizon Scanning Centre (NIHR HSC) EyeOP1® for glaucoma
2012 NIHR Horizon Scanning Centre (NIHR HSC) Dexamethasone sodium phosphate (EryDex) for ataxia telangiectasia – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) DELFIA® Xpress PlGF kit antenatal screening test to predict risk of pre-eclampsia
2012 NIHR Horizon Scanning Centre (NIHR HSC) Umeclidinium and vilanterol for chronic obstructive pulmonary disease
2012 HAYES, Inc. Forkhead Box Protein G1 (FOXG1) testing in congenital variant of Rett Syndrome
2012 HAYES, Inc. MelanoSITE™
2012 HAYES, Inc. Neuroblastoma RAS Viral Oncogene (NRAS) testing to predict treatment response in colorectal cancer
2012 HAYES, Inc. Transcription Factor 4 (TCF4) testing for Pitt-Hopkins Syndrome (PTHS)
2012 HAYES, Inc. VeriStrat® Test to predict response to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC)
2012 HAYES, Inc. DaTscan (123I-Ioflupane; GE Healthcare) for diagnosis of Parkinson's Disease
2012 HAYES, Inc. Diamondback 360° Orbital Atherectomy System (Cardiovascular Systems Inc.) for percutaneous atherectomy of lower-extremity peripheral arterial disease
2012 HAYES, Inc. Esteem Totally Implantable Hearing System (Envoy Medical Corp.) for treatment of moderate to severe sensorineural hearing loss in adults
2012 HAYES, Inc. Genesis II total knee system with oxinium femoral implants (Smith and Nephew Inc.) for total knee arthroplasty
2012 HAYES, Inc. Glucarpidase (Voraxaze; BTG International Ltd.) for treatment of high-dose methotrexate-induced nephrotoxicity
2012 HAYES, Inc. Hysteroscopic morcellation (Truclear Morcellator System; Smith & Nephew Inc.) for treatment of uterine submucosal fibroids and endometrial polyps
2012 HAYES, Inc. Phototherapy for early-stage mycosis fungoides
2012 HAYES, Inc. Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for percutaneous coronary intervention in coronary artery disease
2012 HAYES, Inc. Xoft Axxent eBx electronic brachytherapy system (iCAD Inc.) for early-stage breast cancer
2012 HAYES, Inc. Accelerated partial breast irradiation for breast cancer using conformal and intensity-modulated radiation therapy
2012 HAYES, Inc. Antibiotic-coated sutures
2012 HAYES, Inc. Massage therapy for autism spectrum disorders in children
2012 HAYES, Inc. Screening, Brief Intervention, and Referral to Treatment (SBIRT) using remote interventions for alcohol misuse
2012 HAYES, Inc. Spinal cord stimulation for relief of neuropathic pain
2012 HAYES, Inc. Surgery for treatment of migraine headache
2012 HAYES, Inc. Ultrasound guidance to aid in the placement of peripherally inserted central catheter lines
2012 HAYES, Inc. Whole breast irradiation for breast cancer using three-dimensional conformal radiation therapy or intensity-modulated radiation therapy
2012 Penn Medicine Center for Evidence-based Practice (CEP) Outcomes associated with long-term acute care hospitals
2012 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for admission to long-term acute care hospitals
2012 Penn Medicine Center for Evidence-based Practice (CEP) Specialized neurocritical care units for traumatic brain injury
2012 Penn Medicine Center for Evidence-based Practice (CEP) Screening tests for aspiration and dysphagia
2012 Penn Medicine Center for Evidence-based Practice (CEP) Best practices for preventing aspiration pneumonia in hospitalized patients
2012 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for platelet or plasma transfusion in lumbar puncture patients
2012 Penn Medicine Center for Evidence-based Practice (CEP) CT for acute chest pain
2012 Penn Medicine Center for Evidence-based Practice (CEP) Bone morphogenetic proteins and bone marrow aspirate concentrate for tibial fractures and long bone nonunions
2012 Penn Medicine Center for Evidence-based Practice (CEP) Comparative effectiveness of devices for detection of respiratory distress in post-operative patients
2012 Penn Medicine Center for Evidence-based Practice (CEP) Hyperthermic intraperitoneal chemotherapy
2012 Penn Medicine Center for Evidence-based Practice (CEP) Electromagnetically-assisted feeding tube placement
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Federal structures of the prevention of alcohol misuse among children and youths]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part V: Preterm birth]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vemurafenib for the 1st –line unresectable stage IIIC or IV melanoma
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Erlotinib for the 1st -line treatment of locally advanced or metastatic non-small cell lung cancer with EGFR activating mutations
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Generic indicators for process quality in oncological care. A compendium
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part VI: Health visiting services in the international context and implementation options for Austria]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part VII: Options for an electronic implementation]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part VIII: Budget Impact Analysis]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bevacizumab for previously treated, human epidermal growth factor receptor2-negative metastatic breast cancer
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Appraisal of the quality and accuracy of written consumer health information for patients with chronic myeloid leukaemia on treatment-regimens with dasatinib, imatinib or nilotinib
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Axitinib for 2nd-line metastatic renal cell carcinoma
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Midazolam (BUCCOLAM®)